PATENT CLAIM ANALYSIS

Application Number: 16028235
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.

Claim (Index 1):
A method for treating idiopathic pulmonary fibrosis (IPF) in a subject in need thereof, the method comprising administering an effective amount of an anti-CTGF antibody, thereby treating IPF.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 95.0
- Lexical Diversity: 1.10345
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14398380', '15263767', '12460376', '13374308', '14741747']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.751500665022913
- 35 USC 102 Novelty (BERT): 0.6526572809445691
- Combined Prediction Score: 0.7416163266150786
- Mean Citation Score: 502.49907800000005
- Max Citation Score: 743.4912
- Similarity Product: 568.641267388916

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test